Empagliflozin restores cardiac metabolic flexibility in diet-induced obese C57BL6/J mice

Bingxian Xie, Wesley Ramirez, Amanda M. Mills, Brydie R. Huckestein, Moira Anderson, Martha M. Pangburn, Eric Y. Lang, Steven J. Mullett, Byron W. Chuan, Lanping Guo, IAN J. SIPULA, Christopher Paul O'Donnell, Stacy Gelhaus Wendell, Iain Scott, Michael J. Jurczak
ISSN / E-ISSN
— / —
DOI
10.1016/j.crphys.2022.05.003 ↗
Volume · Issue · Pages
5 · — · 232-239
Publisher
Elsevier BV
Article URL
https://doi.org/10.1016/j.crphys.2022.05.003 ↗
Article details
Unverified
Publication date (each date has its type and source)
01 Jan 2022
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date01 Jan 2022 OpenAlex

Keywords (as given): empagliflozin; SGLT2 inhibitors; diet-induced obesity; insulin resistance; cardiac hypertrophy; myocardial ischemia; heart failure; diabetic cardiomyopathy; cardioprotection

HEC Status at Publication Not the journal's current status

HEC Status at PublicationNot conclusive
Best available information, not a definitive status: Some rows of the HEC list for this period are not yet matched to a journal, so absence cannot be proved. Pending verification.
Journal
Current Research in Physiology
Publication date used
01 Jan 2022 (OpenAlex publication date)
Applicable HEC period
hjrs 2021-22 V2 (version 1) · 01 Jul 2021 – 30 Jun 2022
Category
—
Recognition status
Pending Verification (PERIOD_HAS_UNMATCHED_ROWS)
Source
—
Verification status
Unverified
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.